BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6705330)

  • 21. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Aleman BM; van Leeuwen FE
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress and controversy in treatment of Hodgkin's disease].
    Robak T
    Acta Haematol Pol; 1995; 26(4):343-52. PubMed ID: 8571735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraplegia after 30 Gy involved field irradiation (IFRT) on the mediastinum for Hodgkin's disease.
    Sweldens C; Weytjens R; Thomas J; Huget P; Lemmens J
    Radiother Oncol; 2007 Nov; 85(2):324-5. PubMed ID: 18022266
    [No Abstract]   [Full Text] [Related]  

  • 25. Late effects of radiation therapy in the treatment of Hodgkin's disease.
    Kinsella TJ; Fraass BA; Glatstein E
    Cancer Treat Rep; 1982 Apr; 66(4):991-1001. PubMed ID: 6804091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Bonadonna G
    Ann Oncol; 1992 Sep; 3 Suppl 4():111-5. PubMed ID: 1450071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Some aspects of reproductive function and social adaptation after comprehensive therapy of childhood Hodgkin's disease].
    Susuleva NA; Il'iashenko VV
    Vopr Onkol; 1997; 43(4):399-402. PubMed ID: 9381688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy and Hodgkin's lymphoma.
    Das P; Ha CS; Cox JD
    J Clin Oncol; 2005 Dec; 23(34):8914; author reply 8914-6. PubMed ID: 16314655
    [No Abstract]   [Full Text] [Related]  

  • 30. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late effects of Hodgkin's disease treatment in children.
    Lange BJ; Meadows AT
    Cancer Treat Res; 1989; 41():195-220. PubMed ID: 2577075
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary treatment of early stage Hodgkin's disease].
    Molnár Z; Esik O; Illés A
    Orv Hetil; 2005 Jan; 146(2):57-61. PubMed ID: 15724953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin's disease in the pregnant patient.
    Fisher PM; Hancock BW
    Br J Hosp Med; 1996 Nov 20-Dec 10; 56(10):529-32. PubMed ID: 8958407
    [No Abstract]   [Full Text] [Related]  

  • 34. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K; Utsumi M; Shimoyama M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preliminary results of thyroid function assessment in children and adolescents with Hodgkin's disease (HD) treated according to PGP-HD-97 protocol].
    Moryl-Bujakowska A; Balwierz W; Sztefko K
    Przegl Lek; 2004; 61 Suppl 2():81-4. PubMed ID: 15686053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hodgkin's disease].
    Aoyagi M; Enokihara H; Furusawa S
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):217-30. PubMed ID: 9851125
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hodgkin's disease. The cure and its price].
    Jacquillat C; Auclerc G; Auclerc MF; Weil M
    Rev Prat; 1984 Apr; 34(21):1075-80. PubMed ID: 6718982
    [No Abstract]   [Full Text] [Related]  

  • 39. [Thyroid cancer occurring 15 years after the cure of Hodgkin's disease treated by cervical irradiation, then chemotherapy].
    Najean Y; Messian O
    Nouv Presse Med; 1982 Oct; 11(38):2851-2. PubMed ID: 7177823
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hodgkin's disease in children. Clinical and therapeutic peculiarities].
    Oberlin O; Bayle C; Lemerle J
    Rev Prat; 1984 Apr; 34(21):1081-4. PubMed ID: 6718983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.